From acute to long-term care, ARS services and expertise have led to decreasing resistance and cost, and providing support with new program development and accreditation reviews. Below are some client experiences and testimonials.
- Acute Care Hospital: Decrease in Resistance, Antimicrobial Days of Therapy and Cost
- Long-term Acute Care Hospital: Significant MDRO Decreases
- Skilled Nursing Facilities: Immediate Reduction in Clostridioides difficile and Cost
- Antimicrobial Stewardship Standards: Exceeding The Joint Commission Standards
Decrease in Resistance, Antimicrobial Days of Therapy and Cost in Acute Care Hospitals
One hospital in a large health system established a strong Antimicrobial Stewardship program; however, other system hospitals lagged. There was a need to make a system-wide, cultural shift in prescribing patterns and best practices. Bringing in external experts introduced fresh perspectives.
Significant MDRO Decreases in Long-term Acute Care (LTAC) Hospital
LTAC hospitals contend with limited staffing and budget, and little to no access to Infectious Disease expertise. Unable to hire ID physician or ID pharmacist specialists, the CEO (50 bed long-term acute care hospital with 10 ventilator beds) found a group that met this need and more.
Immediate Reduction in Clostridioides difficile and Cost in Skilled Nursing Facilities
Faced with requirements for antimicrobial stewardship (AMS), tight financial margins, and increasing antimicrobial costs and C. difficile rates, most skilled nursing facilities assign an existing team member the additional task developing an AMS program.
Exceeding The Joint Commission Antimicrobial Stewardship Standards
An acute care hospital with 127 staffed beds was planning for The Joint Commission review. This was the first-time antimicrobial stewardship standards were required and would be reviewed.